Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Assets (2020 - 2025)

Rapid Micro Biosystems' Assets history spans 6 years, with the latest figure at $84.4 million for Q3 2025.

  • For Q3 2025, Assets changed N/A year-over-year to $84.4 million; the TTM value through Sep 2025 reached $84.4 million, changed N/A, while the annual FY2024 figure was $98.2 million, 31.57% down from the prior year.
  • Assets for Q3 2025 was $84.4 million at Rapid Micro Biosystems, up from $75.6 million in the prior quarter.
  • Across five years, Assets topped out at $254.4 million in Q3 2021 and bottomed at $75.6 million in Q2 2025.
  • The 5-year median for Assets is $146.8 million (2023), against an average of $155.5 million.
  • The largest annual shift saw Assets skyrocketed 244.54% in 2021 before it tumbled 35.44% in 2025.
  • A 5-year view of Assets shows it stood at $241.2 million in 2021, then decreased by 20.95% to $190.6 million in 2022, then decreased by 24.76% to $143.5 million in 2023, then crashed by 31.57% to $98.2 million in 2024, then fell by 14.02% to $84.4 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Assets are $84.4 million (Q3 2025), $75.6 million (Q2 2025), and $85.4 million (Q1 2025).